- Tailoring hormone therapy based on women's genetic profiles for IVF improved pregnancy and live birth rates.
- Matching the type of follicle-stimulating hormone to a woman's FSH receptor gene variant resulted in better outcomes.
- Precision medicine in fertility care holds the potential to optimize hormone selection.
- The study revealed a low-cost genetic test could enhance IVF success rates.
- Results supported a precision medicine approach in fertility care, offering promise for increasing live births.
Source: Frontiers in Endocrinology
